Cookies

Like most websites The Translational Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Diagnostics & prognostics

Tools & Techniques Diagnostics & prognostics

IAs - ID'd

| Jonathan James

How the RNA transcriptome of circulating neutrophils could hold the key to identifying intracranial aneurysms – before they rupture.

Disease Area Infectious diseases

Managing Malaria with Smarter Sampling

| Jonathan James

How targeting subclinical populations with a rapid saliva test may aid in the quest to eradicate the disease.

Tools & Techniques Diagnostics & prognostics

Gone Fishing

| Michael Schubert

A magnetic wire inserted into a vein captures circulating tumor cells and cell-free tumor DNA

Tools & Techniques Cancer

Express Insight into Bladder Cancer

| Michael Schubert

Looking at miRNA expression levels may improve our ability to subtype bladder cancers and provide the most appropriate and effective treatment

Research Field Diagnostics & prognostics

Better Biomarkers for AD R&D

| Carlo Medici

For better diagnosis and monitoring of Alzheimer’s disease, as well as drug R&D, we need to move toward widespread use of MRI biomarker imaging.

Disease Area Diagnostics & prognostics

Markers for Prognostic Progress

| Ana Robles

Better lung cancer treatment through biomarkers

Tools & Techniques Diagnostics & prognostics

Screen Test for Spec

| Joanna Cummings

How ATR-FTIR spectroscopy could lead to less invasive cancer prescreening

Tools & Techniques Diagnostics & prognostics

Garbage In, Garbage Out

| Carolyn Compton

Preanalytical variability can be a hidden danger in skewing test results. What's the best way to detect and overcome it?

Tools & Techniques Omics

The Diagnostic Power of DNA Methylation

| Bekim Sadikovic

Machine learning and DNA methylation could open up a new realm of diagnostic possibility

Disease Area Diagnostics & prognostics

Cost-effective Cancer Checks

| William Aryitey

Testing the whole population of women for breast/ovarian cancers mat be more cost-effective than current methods

Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register